Dexcom | DXCM - Stock


Dexcom reported $693.6M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
Align Technology USD 226.34M 1.82M Dec/2025
AtriCure USD 78.49M 459K Dec/2025
Avanos Medical USD 141.3M 6.7M Mar/2026
Baxter International USD 2.32B 84M Mar/2026
Becton, Dickinson and Co. USD 4.08B 191M Dec/2025
Boston Scientific USD 3.12B 174M Mar/2026
Cooper Companies USD 846M 35M Sep/2025
Dexcom USD 693.6M 64.5M Mar/2026
Edwards Lifesciences USD 1.13B 14.7M Dec/2025
Globus Medical USD 759.28M 12.26M Dec/2025
Inogen USD 25.08M 762K Sep/2025
Insulet USD 452.6M 6.3M Dec/2025
Integra LifeSciences USD 495.04M 2.3M Mar/2026
J&J USD 14.58B 392M Mar/2026
Masimo USD 338.6M 20.1M Sep/2025
Medtronic USD 6.31B 153M Dec/2025
Merit Medical Systems USD 352.39M 18.68M Mar/2026
Roche Holding CHF 7.6B 9M Jun/2025
Solventum Corp USD 1.09B 23M Mar/2026
Stryker USD 5.42B 109M Mar/2026
Tandem Diabetes Care USD 128.77M 8.51M Dec/2025
Teleflex USD 802.46M 108.78M Sep/2025
West Pharmaceutical Services USD 452.6M 8.7M Mar/2026
Zimmer Biomet Holdings USD 2.25B 39.6M Mar/2026